Dr Yosselin Arroyo-galvan, MD | |
U.s. Naval Hospital Guam Farenholt Ave, Bldg 50, Agana Heights, GU 96910 | |
(671) 344-9543 | |
Not Available |
Full Name | Dr Yosselin Arroyo-galvan |
---|---|
Gender | Female |
Speciality | Family Medicine |
Location | U.s. Naval Hospital Guam Farenholt Ave, Bldg 50, Agana Heights, Guam |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1942864715 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 0101270703 (Virginia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Yosselin Arroyo-galvan, MD Psc 455 Box 208, Fpo, AP 96540-0003 Ph: (671) 344-9543 | Dr Yosselin Arroyo-galvan, MD U.s. Naval Hospital Guam Farenholt Ave, Bldg 50, Agana Heights, GU 96910 Ph: (671) 344-9543 |
News Archive
Dry weather in the west may lead to an abundance of fertile mosquito breeding grounds as creeks and streams dry up to bogs and puddles faster than usual, while recent storms across the middle of the country and on the East coast could result in more abundant standing water for mosquitoes to lay their eggs.
Cells that consume parts of themselves can stop this process autonomously as well. This was discovered by NWO researcher Judith Klumperman's group, in collaboration with colleagues from the National Institute of Health in Washington. The self-cannibalism is part of the normal digestive process of the cell, but also a survival mechanism in times of famine. This is what makes it difficult for doctors to 'starve out' cancer cells, for instance. The research results were published on 6 June in Nature.
Abatacept, a member of a new class of drug that targets immune cells to treat rheumatoid arthritis (RA), is effective against RA, according to a new Cochrane Systematic Review. The review examines recent trials to assess safety and efficacy of the drug.
Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has accepted for review the Biologics License Application (BLA) for MK-3475, Merck's investigational anti-PD-1 antibody, for the treatment of unresectable or metastatic melanoma in patients who have been previously treated with ipilimumab.
› Verified 7 days ago
Dr. Amanda Elizabeth Waller, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: Us Naval Hospital Guam, Farenholt Ave, Bldg 50, Agana Heights, GU 96910 Phone: 671-344-9222 | |
Kelsey Campbell, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: Bldg #50 Farenholt Ave, Agana Heights, GU 96910 Phone: 671-344-9543 | |
Daniel Zhang, Family Medicine Medicare: Medicare Enrolled Practice Location: Bldg #50, Farenholt Ave, Agana Heights, GU 96910 Phone: 671-344-9202 | |
Cameron William Brassfield, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: Bldg #50, Farenholt Ave, Agana Heights, GU 96910 Phone: 671-344-9340 | |
Sara Xiomara Rodriguez, PA-C Family Medicine Medicare: Not Enrolled in Medicare Practice Location: Naval Hospital Guam, Bldg 1 Fareholt Ave, Agana Heights, GU 96910 Phone: 671-344-9340 | |
Dr. Cody Sterling Holmes, DO Family Medicine Medicare: Medicare Enrolled Practice Location: Bld 51 Farenholt Ave, Agana Heights, GU 96910 Phone: 671-344-9202 |